Core Viewpoint - The Ministry of Civil Affairs and eight other departments have jointly issued measures to stimulate the vitality of various elderly care service providers, create a favorable investment environment, and promote the development of the silver economy to better meet the diverse needs of the elderly [1][3] Group 1: Policy Measures - The measures aim to optimize the supply of elderly care services and age-friendly products, encouraging community-based operations and integration of resources to enhance service delivery [4] - The initiative supports the development of home care services for the elderly, including professional medical accompaniment and mobile bathing services [4] - There is a focus on promoting smart rehabilitation aids and age-appropriate food and clothing products, enhancing the living environment for the elderly [4] Group 2: Market Dynamics - By the end of 2025, there will be 41,700 elderly care institutions in China, with 722,000 employees, reflecting a 12.2% year-on-year increase, and 52.2% of these institutions will be privately owned [5] - Social forces are becoming the main contributors to the diversified supply of elderly care services, indicating a shift in the service landscape [5] Group 3: Technological Support - The measures encourage technological advancements in elderly care, integrating big data, AI, and other technologies for health monitoring and personalized services [6] - There is a push for the development of elderly care robots and smart home technologies to meet the daily care and emotional support needs of the elderly [6] - The market is expected to see new opportunities driven by the integration of technology in elderly care, with a focus on smart home products and AI solutions [7]

格隆汇1月13日丨尔康制药(300267.SZ)在投资者互动平台表示，公司业务未涉及脑机接口领域，公司将 积极关注行业前沿技术的发展。 ...

Core Insights - Strong Brain Technology has reportedly submitted a confidential IPO application to the Hong Kong Stock Exchange, positioning itself as the first technology-based public company in China's brain-computer interface (BCI) sector [1][3] - The company recently completed approximately 2 billion yuan in Pre-IPO financing, achieving a post-investment valuation exceeding 1.3 billion USD [1][3] - The global brain-computer interface market is projected to grow from 1.2 billion USD in 2019 to nearly 2 billion USD in 2023, with a compound annual growth rate (CAGR) exceeding 13% [6] Company Developments - Strong Brain Technology aims to assist 1 million physically disabled individuals by providing neural-controlled prosthetics and improve the lives of 10 million patients suffering from brain-related disorders over the next five to ten years [3] - The company is focused on non-invasive solutions, developing super sensors to detect human neural signals, differentiating itself from competitors like Neuralink [3] - In 2025, the company plans to accelerate its technology innovation and industrialization processes, launching a new generation of bionic dexterous hands for smart manufacturing applications [4] Market Trends - The brain-computer interface sector has been included in China's "14th Five-Year Plan" as one of the six future industries, indicating its transition from laboratory research to a national strategic focus [6] - Following the announcement of BCI-related developments, several companies in the sector, such as Innovation Medical and Rock Mountain Technology, experienced significant stock price movements, highlighting market sensitivity to BCI concepts [6][7] - The capital market's reaction has been mixed, with some companies facing scrutiny from regulatory bodies regarding their BCI-related announcements [6][7]

每经记者｜杨欢 每经编辑｜刘艳美 据文汇报消息，1月13日，国内植入式柔性脑机接口领军企业上海脑虎科技有限公司的"超级工厂"项目在江西省赣江新区正式动 工，预计于2026年下半年建成并投入运营。这标志着我国在这一前沿科技领域从实验室向规模化量产迈出了关键一步。 上海脑虎科技有限公司成立于2021年，是目前全球唯一同时拥有实时汉语及运动解码技术的脑机接口企业，目前已完成了从柔 性电极、脑电芯片、植入体、手术机器人到脑机操作系统的全链条自主研发，是除了埃隆·马斯克的美国神经联接公司 （Neuralink）以外，国内首家、国际第二家有脑机接口全链条量产能力的企业。此前，脑虎研发的国内首款、全球第二款"全植 入、全无线、全功能"脑机接口已成功完成首例临床试验，计划于今年开展多中心临床研究。 解读：2025年被称为"脑机接口元年"。工业和信息化部等七部委联合印发《关于推动脑机接口产业创新发展的实施意见》，在 国家层面首次系统性规划脑机接口产业发展路径。此后在国家"十五五"规划建议中也提出，前瞻布局未来产业，将"脑机接 口"列为新的经济增长点之一。 从地方政策来看，早在2023年，脑机接口就被纳入江西省未来产业规划；20 ...

"超级工厂"之所以落地江西，除了当地较低的人力与土地成本、丰富的原材料资源外，也得益于其集成 电路、医疗器械、生物医药等完善的制造业体系——如吉安合力泰（002217）的精密传感器、赣州同兴 达（002845）的嵌入式系统、南昌晶能光电的光电子器件等，为脑机接口设备提供了关键配套支持。 江西地处长江中下游，与长三角地区相邻，是长三角一体化发展的腹地。此前江西就曾提出，要促进更 多科技成果在江西转化落地。最新公布的江西"十五五"规划建议还提出，主动对接和服务长三角一体化 发展，搭建跨区域产业转移合作平台，健全利益共享机制。 以此次脑虎科技"超级工厂"为例，作为"强磁核"，其将联动上下游供应链企业，在赣江新区打造覆盖核 心部件、研发服务与临床应用的完整产业矩阵，加速形成具有全球竞争力的脑机接口产业集群。 从地方政策来看，早在2023年，脑机接口就被纳入江西省未来产业规划；2025年11月，《江西省加快脑 机接口技术和产业发展若干措施》出台，提出了11条具体举措，要拥抱这个"超级风口"，抢抓未来产业 机遇。 从企业落地来看，江西的布局还可以继续倒推——2019年，国内侵入式脑机接口领域尚处冷门时，时任 中国科学院上 ...

Industry Overview - The Ministry of Civil Affairs and eight other departments have introduced measures to cultivate the elderly care service industry and promote the silver economy, emphasizing the encouragement of elderly care technology research and product development [1] - The aging population in China, with over 310 million people aged 60 and above, and the shortage of caregiving personnel are driving the initial phase of large-scale application of elderly care robots [1] - The elderly care robot industry is expected to transition from "function realization" to "experience optimization" due to advancements in AI, 5G, cloud computing, and core components, with a projected market size exceeding 66 billion yuan by 2030 [2] Company Insights - Ousheng Electric has been deeply involved in the elderly care robot sector for many years, achieving a high level of market recognition and meeting conditions for large-scale production with its fifth-generation ICARE-BOT wearable intelligent nursing system [3] - The ICARE-BOT features advanced intelligent recognition, automatic care, and health monitoring technologies, and has obtained multiple international certifications, allowing for global market access [3] - Yueshen Health's joint venture, Shanghai Yueshen Jinyi Robot Technology Co., Ltd., focuses on the development, production, and sales of robots for medical rehabilitation and elderly care, with products already in practical use in cognitive, neurological, and orthopedic rehabilitation [3]

Group 1: Market Overview - The A-share market experienced a collective pullback on January 13, with the Shanghai Composite Index down 0.64%, ending a 17-day winning streak, while the Shenzhen Component Index fell 1.37% and the ChiNext Index dropped 1.96% [1] - The trading volume in the Shanghai, Shenzhen, and Beijing markets exceeded 3.6 trillion yuan, marking a slight increase from the previous day and setting a new historical high [1] Group 2: AI Medical Sector - The AI medical sector continues to thrive, with significant gains; the Hong Kong medical ETF (159137) surged by 3.44% and reached a near-limit-up level, while the largest A-share medical ETF (512170) hit a three-month high with a peak increase of 3.67% [4][6] - AI medical concept stocks saw substantial increases, with Ark Health rising over 76% after announcing a collaboration with Tencent Health on an "AI + chronic disease management" plan [4][8] Group 3: Banking Sector - The banking sector showed resilience, with several banks like Ningbo Bank and Hangzhou Bank seeing gains of over 4% and 3% respectively, while the top banking ETF (512800) rose by 0.37% [11][13] - The first bank executive buyback announcement of 2026 was made by Chongqing Rural Commercial Bank, indicating confidence in the company's fundamentals [13] - Historical data suggests that the banking sector tends to perform well before the Spring Festival, with an average absolute return of 4.4% [16] Group 4: Commercial Aerospace Sector - The commercial aerospace sector faced volatility, with the general aviation ETF (159231) experiencing a significant drop of 7.27%, despite a net inflow of 46 million yuan on the same day [18][19] - The sector's performance has been mixed, with 44 out of 50 component stocks declining, while some stocks like Tianyin Electromechanical and Haige Communication saw gains [18] Group 5: Future Outlook - Analysts suggest that the current market liquidity is ample, and thematic trading is expected to continue, with a focus on the "Musk Chain" and non-bank financial investment opportunities [3] - The market is anticipated to exhibit structural opportunities, with a theme-driven approach and rapid capital rotation among different industry lines [3]

Investment Rating - The report rates the AI healthcare industry as "Overweight," indicating a positive outlook for the sector compared to the overall market performance [2][19]. Core Insights - The launch of OpenAI's ChatGPT Health on January 8, 2026, marks a significant advancement in AI healthcare, integrating user health data for personalized health analysis and recommendations. The user base of Ant Group's AI tool, Antifufu, has also seen substantial growth, surpassing 30 million monthly active users [2][5]. - The report highlights the rapid penetration of AI health management in the consumer market, driven by advancements in technology and user engagement [2][5]. - Key areas of progress include AI consultations, brain-computer interfaces, and AI-driven drug development, with notable advancements from companies like Neuralink and Retro Biosciences [10][13][14]. Summary by Sections AI Health Management - OpenAI's ChatGPT Health integrates personal health data, offering features such as test report interpretation, health management, and personalized diet and fitness recommendations. The tool emphasizes user privacy and data security [4][7]. - Antifufu has integrated over 100 AI functions, connecting users with 300,000 real doctors and over 500 AI avatars, achieving a doubling in user engagement metrics within a month [8][9]. AI Consultation and Drug Development - The report notes significant improvements in AI consultation tools, with various companies like Weining Health and JD Health being highlighted for their contributions to AI health management [15]. - In drug development, OpenAI's collaboration with Retro Biosciences has led to the clinical advancement of a small molecule drug targeting aging, showcasing the potential of AI in pharmaceutical innovation [13][14]. Market Performance and Company Valuations - The report provides a valuation table for key companies in the AI healthcare sector, indicating projected net profits and market capitalizations for 2024 to 2027. For instance, Weining Health is projected to have a market cap of 31 billion with a net profit of 3.5 billion by 2026 [14].

（文章来源：证券日报） 证券日报网讯 1月13日，昭衍新药在互动平台回答投资者提问时表示，公司非人灵长类模型主要是自 用，用于非临床安评实验相关研究，不涉及脑机接口业务，相关信息请以公司披露的相关公告为准。 ...

Core Viewpoint - The collaboration between Youke De and Brain Tiger Technology is highlighted, focusing on their strategic partnership in advancing cloud processing of brain data and exploring applications of brain-computer interface technology in medical rehabilitation [1] Group 1: Strategic Partnership - Youke De has established a strategic partnership with Brain Tiger Technology since 2022, aimed at promoting the cloud processing of brain data [1] - In 2023, both companies, along with Fudan University Huashan Hospital, were selected as members of the Shanghai Future Industry Brain-Computer Interface Expert Committee [1] Group 2: Research and Development - In 2024, Youke De and Brain Tiger Technology deepened their collaboration by participating in significant research project applications in the brain-computer interface field in Shanghai [1] - The joint development of an "implantable speech synthesis brain-computer interface product" aims to assist patients with aphasia in regaining some language functions [1] Group 3: Technological Infrastructure - Youke De has successfully built a GPU computing platform and a corpus data management system, leveraging its high-performance computing and reliable data storage capabilities [1] - As a leading neutral third-party cloud computing service provider in China, Youke De efficiently provides intelligent computing power to various industries while exploring AI application scenarios and commercial pathways [1]